This interview is disseminated on behalf of Aftermath Silver Ltd. Aftermath Silver (TSXV: AAG | OTCQX: AAGFF | FRA: FLM1) President, CEO, and Director Ralph Rushton joins Stocks to Watch to discuss the latest drilling results from the Berenguela silver-copper-manganese deposit in Peru, including high-grade intercepts, ongoing infill and geotechnical drilling, and the company’s broader exploration strategy.

Learn more: https://aftermathsilver.com/


Watch the full YouTube interview here: https://youtu.be/cA5F8NXUqG0

And follow us to stay updated: https://www.youtube.com/GlobalOneMedia

This interview is disseminated on behalf of Conexeu Sciences Inc.

Conexeu Sciences (NASDAQ: CNXU) President and CEO Miles Harrison discusses how the company’s regenerative medicine platform could address the growing demand for tissue restoration driven by GLP-1 weight loss medications, extracellular matrix technology, multi-market strategy, and the future of bioregeneration.

Learn more: https://www.conexeu.com/

Watch the full YouTube interview here: https://youtu.be/FJUXvMrH5hU

And follow us to stay updated: https://www.youtube.com/GlobalOneMedia

This interview is disseminated on behalf of The FUTR Corporation.

FUTR Corporation (TSXV: FTRC | OTCQB: FTRCF | FSE: QA20) CEO Alex McDougall joins Stocks to Watch to discuss the company’s AI-powered financial platform and its strategy for monetizing consumer data through the automotive sector. McDougall also discusses the FUTR Agent App, which stores, organizes, and monetizes users’ personal financial data through FUTR Tokens, as well as the company’s joint venture with EQIBank to establish an AI-agent-native digital banking platform targeting more than 100 countries.

Learn more: https://thefutrcorp.com/#hero

Watch the full YouTube interview here: https://youtu.be/Oap-sm1AdjU

And follow us to stay updated: https://www.youtube.com/GlobalOneMedia

Gold and silver mining stock analyst Don Durrett of GoldStockData.com shares a condensed version of his framework for gaining an edge when investing in gold and silver mining stocks, covering producers, developers, and explorers.

Discover Don Durrett's resource for gold and silver stock investors: https://www.goldstockdata.com

Watch the full YouTube interview here: https://youtu.be/zCboj2XRzEU

And follow us to stay updated: https://www.youtube.com/GlobalOneMedia

This interview is disseminated on behalf of Cardiol Therapeutics Inc.

In this episode of Stocks to Watch, we sit down with David Elsley, President and CEO of Cardiol Therapeutics (NASDAQ: CRDL | TSX: CRDL), to discuss the company's late-stage clinical development program targeting inflammation-driven heart conditions, including recurrent pericarditis and acute myocarditis.

Learn more: https://www.cardiolrx.com

Watch the full YouTube interview here: https://youtu.be/NXkzgfWHQnA

And follow us to stay updated: https://www.youtube.com/GlobalOneMedia

This interview is disseminated on behalf of Planet Ventures Inc.

As a new frontier in investing takes shape, Planet Ventures Inc. (CSE: PXI | OTC: PNXPF | FSE: P6U) is opening doors for retail investors seeking opportunities in the space sector. CEO Etienne Moshevich joins us for an exclusive interview to discuss the company’s background, outlook, and strategy for building exposure while managing risk in this emerging sector.

Discover their portfolio on their website: https://www.planetventuresinc.com/

Watch the full YouTube interview here: https://youtu.be/IoqCj9engT4

And follow us to stay updated: https://www.youtube.com/GlobalOneMedia

This interview is disseminated on behalf of North American Niobium and Critical Minerals Corp.

Murray Nye, CEO and Director of North American Niobium (CSE: NIOB | OTCQB: NIOMF | FSE: KS82.F), discusses the company's exploration program targeting niobium and total rare earths across its portfolio of assets in Quebec's Grenville Province.

Learn more about North American Niobium: https://northamericanniobium.com

Watch the full YouTube interview here: https://youtu.be/XsB7n6qR7sU

And follow us to stay updated: https://www.youtube.com/GlobalOneMedia

This interview is disseminated on behalf of Medicus Pharma Ltd.

In this episode of Stocks to Watch, we are joined by Medicus Pharma (NASDAQ: MDCX) Executive Chairman and CEO Dr. Raza Bokhari to discuss the company's promising Phase 2 results for SkinJect, its innovative skin cancer treatment, and what lies ahead for the company across oncology, rare diseases, and prostate cancer.

Learn more about Medicus Pharma: https://medicuspharma.com/

Watch the full YouTube interview here: https://youtu.be/4GZIBnS2KZ0

And follow us to stay updated: https://www.youtube.com/GlobalOneMedia